{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:44:13Z","timestamp":1784547853261,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"17","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005036","name":"University of Bergen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Heart Disease at Haukeland University Hospital"},{"DOI":"10.13039\/501100004257","name":"Western Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation to Promote Research into Functional Vitamin B12 Deficiency"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims\u2003<\/jats:title>\n                  <jats:p>Blockade of \u03b2-adrenoceptors reduces sympathetic nervous system activity and improves survival in patients with heart failure with reduced left ventricular ejection fraction (HFrEF); however, any improvement in longevity among patients with coronary heart disease (CHD) but without HFrEF remains uncertain. Vitamin A has been linked to the activation of tyrosine hydroxylase, the rate-limiting enzyme in the catecholamine synthesis pathway. We investigated if vitamin A status modified the association of \u03b2-blocker use with the risk of all-cause mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results\u2003<\/jats:title>\n                  <jats:p>A total of 4118 patients undergoing elective coronary angiography for suspected stable angina pectoris, of whom the majority had normal left ventricular ejection fraction (LVEF) were studied. Hazard ratios (HRs) of all-cause mortality comparing treatment vs. non-treatment of \u03b2-blockers according to the tertiles of serum vitamin A were explored in Cox proportional hazards regression models. During a median follow-up of 10.3\u2009years, 897 patients (21.8%) died. The overall LVEF was 65% and 283 (6.9%) had anamnestic HF. After multivariable adjustments for traditional risk factors, medical history, and drug therapies of cardiovascular disease, \u03b2-blocker treatment was inversely associated with the risk of all-cause mortality [HR : 0.84; 95% CI (confidence interval), 0.72\u20130.97]. However, the inverse association was generally stronger among patients in the upper serum vitamin A tertile (HR :0.66; 95% CI, 0.50\u20130.86; Pinteraction = 0.012), which remained present after excluding patients with LVEF\u2009&amp;lt;\u200940%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>In patients with suspected CHD, \u03b2-blocker treatment was associated with improved survival primarily among patients with high serum vitamin A levels.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaa158","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T04:13:55Z","timestamp":1609474435000},"page":"1897-1902","source":"Crossref","is-referenced-by-count":8,"title":["\u03b2-blocker use and risk of all-cause mortality in patients with coronary heart disease: effect modification by serum vitamin A"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-8165","authenticated-orcid":false,"given":"Indu","family":"Dhar","sequence":"first","affiliation":[{"name":"Mohn Nutrition Research Laboratory, Department of Clinical Sciences, University of Bergen, N-5021 Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9391-8352","authenticated-orcid":false,"given":"Gard F T","family":"Svingen","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1805-5221","authenticated-orcid":false,"given":"Thomas","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-5075","authenticated-orcid":false,"given":"Vegard","family":"Lysne","sequence":"additional","affiliation":[{"name":"Mohn Nutrition Research Laboratory, Department of Clinical Sciences, University of Bergen, N-5021 Bergen, Norway"},{"name":"Department of Heart Disease, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen \u00d8","family":"Bj\u00f8rnestad","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-0571","authenticated-orcid":false,"given":"Per M","family":"Ueland","sequence":"additional","affiliation":[{"name":"Bevital AS, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottar K","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[{"name":"Mohn Nutrition Research Laboratory, Department of Clinical Sciences, University of Bergen, N-5021 Bergen, Norway"},{"name":"Department of Heart Disease, Haukeland University Hospital, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"2022020822413129000_zwaa158-B1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000047041.66447.29","article-title":"American College of Cardiology, American Heart Association ACC\/AHA 2002 guideline update for the management of patients with stable angina","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"2022020822413129000_zwaa158-B2","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1161\/01.CIR.0000070983.15903.A2","article-title":"Beta-adrenergic blockers","volume":"107","author":"Frishman","year":"2003","journal-title":"Circulation"},{"key":"2022020822413129000_zwaa158-B3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40256-017-0221-8","article-title":"The real role of \u03b2-blockers in daily cardiovascular therapy","volume":"17","author":"D\u00e9zsi","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"2022020822413129000_zwaa158-B4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022020822413129000_zwaa158-B5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"2022020822413129000_zwaa158-B6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"2022020822413129000_zwaa158-B7","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of \u03b2 blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"2022020822413129000_zwaa158-B8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2022020822413129000_zwaa158-B9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.amjcard.2004.12.008","article-title":"Intermountain Heart Collaborative Study G: Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure","volume":"95","author":"Bunch","year":"2005","journal-title":"Am J Cardiol"},{"key":"2022020822413129000_zwaa158-B10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/heartjnl-2014-305719","article-title":"Prognostic impact of \u03b2-Blocker use in patients with stable coronary artery disease","volume":"100","author":"Bauters","year":"2014","journal-title":"Heart"},{"key":"2022020822413129000_zwaa158-B11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"2022020822413129000_zwaa158-B12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijcard.2016.08.239","article-title":"\u0392-blockers do not provide survival benefit in a population with angiographic coronary artery disease without myocardial infarction or reduced ejection fraction: a meta-analysis","volume":"223","author":"Jaradat","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022020822413129000_zwaa158-B13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/advances\/nmz131","article-title":"Retinol, retinoic acid, and retinol-binding protein 4 are differentially associated with cardiovascular disease, type 2 diabetes, and obesity: an overview of human studies","volume":"11","author":"Olsen","year":"2020","journal-title":"Adv Nutr"},{"key":"2022020822413129000_zwaa158-B14","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1177\/2047487318788587","article-title":"The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A","volume":"25","author":"Olsen","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2022020822413129000_zwaa158-B15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00394-019-02086-2","article-title":"Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease","volume":"59","author":"Olsen","year":"2020","journal-title":"Eur J Nutr"},{"key":"2022020822413129000_zwaa158-B16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1471-4159.2004.02770.x","article-title":"Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells","volume":"91","author":"Lee","year":"2004","journal-title":"J Neurochem"},{"key":"2022020822413129000_zwaa158-B17","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1471-4159.2007.04935.x","article-title":"Retinol activates tyrosine hydroxylase acutely by increasing the phosphorylation of serine40 and then serine31 in bovine adrenal chromaffin cells","volume":"103","author":"Gelain","year":"2007","journal-title":"J Neurochem"},{"key":"2022020822413129000_zwaa158-B18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0169-328X(89)90059-4","article-title":"Changes in expression of tyrosine hydroxylase immunoreactivity in human SMS-KCNR neuroblastoma following retinoic acid or phorbol ester-induced differentiation","volume":"5","author":"Pennypacker","year":"1989","journal-title":"Brain Res Mol Brain Res"},{"key":"2022020822413129000_zwaa158-B19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J Neurochem"},{"key":"2022020822413129000_zwaa158-B20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1471-4159.2006.03866.x","article-title":"Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor","volume":"98","author":"Jeong","year":"2006","journal-title":"J Neurochem"},{"key":"2022020822413129000_zwaa158-B21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000014450.40853.2B","article-title":"All-trans-retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethyl arginine dimethylaminohydrolase","volume":"90","author":"Achan","year":"2002","journal-title":"Circ Res"},{"key":"2022020822413129000_zwaa158-B22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jama.300.7.795","article-title":"Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial","volume":"300","author":"Ebbing","year":"2008","journal-title":"JAMA"},{"key":"2022020822413129000_zwaa158-B23","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/ATVBAHA.113.301714","article-title":"Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris","volume":"33","author":"Svingen","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022020822413129000_zwaa158-B24","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/rcm.5073","article-title":"Determination of vitamins A, D and E in a small volume of human plasma by a high-throughput method based on liquid chromatography\/tandem mass spectrometry","volume":"25","author":"Midttun","year":"2011","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2022020822413129000_zwaa158-B25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1741826711409325","article-title":"Long-term beta blockers for stable angina: systematic review and meta-analysis","volume":"19","author":"Shu de","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"2022020822413129000_zwaa158-B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2007.02.077","article-title":"Vitamin A deficiency induces a decrease in EEG delta power during sleep in mice","volume":"1150","author":"Kitaoka","year":"2007","journal-title":"Brain Res"},{"key":"2022020822413129000_zwaa158-B27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.coph.2012.12.002","article-title":"Beta blockers, nitric oxide, and cardiovascular disease","volume":"13","author":"Vanhoutte","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"2022020822413129000_zwaa158-B28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.5603\/CJ.a2015.0042","article-title":"Influence of \u03b2-blockers on endothelial function: a meta-analysis of randomized controlled trials","volume":"22","author":"Peller","year":"2015","journal-title":"Cardiol J"},{"key":"2022020822413129000_zwaa158-B29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.80.1.45","article-title":"\u03b2 adrenergic blockers lower renin in patients with ACE inhibitors and diuretics","volume":"80","author":"Holmer","year":"1998","journal-title":"Heart"},{"key":"2022020822413129000_zwaa158-B30","doi-asserted-by":"crossref","first-page":"F909","DOI":"10.1152\/ajprenal.2001.281.5.F909","article-title":"Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis","volume":"281","author":"Dechow","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022020822413129000_zwaa158-B31","first-page":"1439","article-title":"Serum levels of vitamin A and carotenoids as reflectors of nutritional status","volume":"73","author":"Olson","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"2022020822413129000_zwaa158-B32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/ajkd.2002.31389","article-title":"Relationship of serum antioxidant vitamins to serum creatinine in the US population","volume":"39","author":"Chen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2022020822413129000_zwaa158-B33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"2022020822413129000_zwaa158-B34","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0002-9149(96)00191-9","article-title":"Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group","volume":"77","author":"Jonas","year":"1996","journal-title":"Am J Cardiol"},{"key":"2022020822413129000_zwaa158-B35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.mayocp.2017.11.019","article-title":"Risk of all-cause mortality in diabetic patients taking beta-blockers","volume":"93","author":"Tsujimoto","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"2022020822413129000_zwaa158-B36","first-page":"291","article-title":"R. Effect of \u03b2-blocker therapy in diabetic patients with stable coronary heart disease: a meta-analysis","volume":"16","author":"Malik","year":"2019","journal-title":"J Geriatr Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/17\/1897\/42379849\/zwaa158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/17\/1897\/42379849\/zwaa158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T22:43:29Z","timestamp":1644360209000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/28\/17\/1897\/6168592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":36,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaa158","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,3,8]]}}}